ITI Life Sciences commits £30 million to new R&D programme
New company - Stirling Medical Innovations - established to develop near-patient and home use diagnostic tests based on novel biomarker technologies
The programme resulted from ITI Life Sciences' Market and Technology Analysis of the healthcare market. This identified opportunities for commercialisation with the aim of stimulating the growth of Scotland's life sciences sector. To deliver the programme, ITI Life Sciences, together with Scottish Development International and Scottish Enterprise, has succeeded in attracting Inverness Medical Innovations Inc. (IMI) to Scotland. IMI is a leading global developer, manufacturer and marketer of rapid diagnostic tests for both the home use and professional markets.
As part of the programme, IMI has set up Stirling Medical Innovations Ltd, a new Scottish research, development and manufacturing company to be based in Stirling. Over the next three years IMI plans to invest £37.5 million in the R&D programme and following completion, a further £30 million in manufacturing and the commercialisation of new products.
The programme is aimed identifying novel biomarkers and technologies to develop near-patient and home use tests, both of which have been identified as growing markets by ITI Life Sciences in its Market and Technology Analysis foresighting activity. In the programme, Stirling Medical Innovations plans to develop a new diagnostic platform for use in human health tests. ITI Life Sciences, in conjunction with other companies, will then leverage the technology underpinning this platform in other areas, such as bio-defence, veterinary care, environmental monitoring and food testing.
Other news from the department science
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.